Drug Profile
Benzhydrocodone/paracetamol - Zevra Therapeutics
Alternative Names: Acetaminophen/benzhydrocodone; Acetaminophen/KP-201; AG-APADAZ; Apadaz; APAP/KP-201; Benzhydrocodone and acetaminophen; Benzhydrocodone/acetaminophen; KP-201/acetaminophen; KP-201/APAP; KP201/IR; Paracetamol/benzhydrocodone; Paracetamol/KP-201Latest Information Update: 16 Apr 2024
Price :
$50
*
At a glance
- Originator KemPharm
- Developer Zevra Therapeutics
- Class Acetanilides; Antipyretics; Benzoates; Epoxy compounds; Morphinans; Non-opioid analgesics; Opioid analgesics; Opioid peptides; Small molecules
- Mechanism of Action Opioid receptor agonists; Prostaglandin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Market Withdrawal Acute pain